CODX vs PFE
Co-Diagnostics, Inc. Common Stock (CODX) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Co-Diagnostics, Inc. Common Stock (CODX) is a medical devices company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported CODX revenue for 2024-12-31 was $3.9M. Net income was -$37.6M. Revenue was down 42.5% from 2023-12-31 to 2024-12-31. CODX currently screens at market cap $31.4M.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
CODX currently screens at market cap $31.4M. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the CODX and PFE stock pages for the full models.
Not investment advice.